AngioDynamics (ANGO) announced it received U.S. FDA 510(k) clearance for the NanoKnife System for prostate tissue ablation. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ANGO: AngioDynamics Shareholder Approvals and Director Elections AngioDynamics and UCLH launch study of ‘long term effects’ of NanoKnife System
